Columvi 10 mg concentrate for solution for infusion, Glofitamab, Gazyvaro 1,000 mg concentrate for solution for infusion., RoActemra 20 mg/mL concentrate for solution for infusion
NP30179
Phase 2 small_molecule active
Quick answer
Columvi 10 mg concentrate for solution for infusion, Glofitamab, Gazyvaro 1,000 mg concentrate for solution for infusion., RoActemra 20 mg/mL concentrate for solution for infusion for Relapsed/refractory B-cell non-Hodgkin’s lymphoma (r/r NHL) is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Relapsed/refractory B-cell non-Hodgkin’s lymphoma (r/r NHL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active